01 1Qilu Pharmaceutical
01 1OLANZAPINE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-04
Pay. Date : 2022-09-29
DMF Number : 25175
Submission : 2011-07-29
Status : Active
Type : II
20
Qilu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is OLANZAPINE, with a corresponding US DMF Number 25175.
Remarkably, this DMF maintains an Active status since its submission on July 29, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 04, 2022, and payment made on September 29, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
